These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31080798)

  • 21. Novel Old Yellow Enzyme Subclasses.
    Peters C; Frasson D; Sievers M; Buller R
    Chembiochem; 2019 Jun; 20(12):1569-1577. PubMed ID: 30758121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectivity through discriminatory induced fit enables switching of NAD(P)H coenzyme specificity in Old Yellow Enzyme ene-reductases.
    Iorgu AI; Hedison TM; Hay S; Scrutton NS
    FEBS J; 2019 Aug; 286(16):3117-3128. PubMed ID: 31033202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the stereochemical course of ene reductase-catalysed reactions by deuterium labelling.
    Brenna E; Fronza G; Fuganti C; Parmeggiani F
    Isotopes Environ Health Stud; 2015; 51(1):24-32. PubMed ID: 25675259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revealing Additional Stereocomplementary Pairs of Old Yellow Enzymes by Rational Transfer of Engineered Residues.
    Nett N; Duewel S; Richter AA; Hoebenreich S
    Chembiochem; 2017 Apr; 18(7):685-691. PubMed ID: 28107586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the stereoselectivity of carbonyl reductases toward the reduction of OPBE and docking analysis.
    Chen R; Deng J; Lin J; Yin X; Xie T; Yang S; Wei D
    Biotechnol Appl Biochem; 2016 Jul; 63(4):465-70. PubMed ID: 25989134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ene reductase from Clavispora lusitaniae for asymmetric reduction of activated alkenes.
    Ni Y; Yu HL; Lin GQ; Xu JH
    Enzyme Microb Technol; 2014 Mar; 56():40-5. PubMed ID: 24564901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds.
    Winkler CK; Tasnádi G; Clay D; Hall M; Faber K
    J Biotechnol; 2012 Dec; 162(4):381-9. PubMed ID: 22498437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering of an ene-reductase for producing the key intermediate of antiepileptic drug Brivaracetam.
    Sun L; Liu Y; Song H; Hao J; Lin L
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1649-1661. PubMed ID: 36710288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhodococcus strains as source for ene-reductase activity.
    Chen BS; Médici R; van der Helm MP; van Zwet Y; Gjonaj L; van der Geest R; Otten LG; Hanefeld U
    Appl Microbiol Biotechnol; 2018 Jul; 102(13):5545-5556. PubMed ID: 29705954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocatalytic reduction of activated CC-bonds and beyond: emerging trends.
    Winkler CK; Faber K; Hall M
    Curr Opin Chem Biol; 2018 Apr; 43():97-105. PubMed ID: 29275291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioreduction of alpha-methylcinnamaldehyde derivatives: chemo-enzymatic asymmetric synthesis of Lilial and Helional.
    Stueckler C; Mueller NJ; Winkler CK; Glueck SM; Gruber K; Steinkellner G; Faber K
    Dalton Trans; 2010 Sep; 39(36):8472-6. PubMed ID: 20461254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoenzymatic asymmetric synthesis of pregabalin precursors via asymmetric bioreduction of β-cyanoacrylate esters using ene-reductases.
    Winkler CK; Clay D; Davies S; O'Neill P; McDaid P; Debarge S; Steflik J; Karmilowicz M; Wong JW; Faber K
    J Org Chem; 2013 Feb; 78(4):1525-33. PubMed ID: 23316696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of an ene-reductase from Meyerozyma guilliermondii for asymmetric bioreduction of α,β-unsaturated compounds.
    Zhang B; Zheng L; Lin J; Wei D
    Biotechnol Lett; 2016 Sep; 38(9):1527-34. PubMed ID: 27193896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermal, electrochemical and photochemical reactions involving catalytically versatile ene reductase enzymes.
    Toogood HS; Scrutton NS
    Enzymes; 2020; 47():491-515. PubMed ID: 32951833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming co-product inhibition in the nicotinamide independent asymmetric bioreduction of activated C=C-bonds using flavin-dependent ene-reductases.
    Winkler CK; Clay D; van Heerden E; Faber K
    Biotechnol Bioeng; 2013 Dec; 110(12):3085-92. PubMed ID: 23794404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrile as Activating Group in the Asymmetric Bioreduction of β-Cyanoacrylic Acids Catalyzed by Ene-Reductases.
    Winkler CK; Clay D; Turrini NG; Lechner H; Kroutil W; Davies S; Debarge S; O'Neill P; Steflik J; Karmilowicz M; Wong JW; Faber K
    Adv Synth Catal; 2014 May; 356(8):1878-1882. PubMed ID: 26190962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the active site of Old Yellow Enzyme. Role of histidine 191 and asparagine 194.
    Brown BJ; Deng Z; Karplus PA; Massey V
    J Biol Chem; 1998 Dec; 273(49):32753-62. PubMed ID: 9830019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vitro ketone reduction of warfarin and analogues. Substrate stereoselectivity, product stereoselectivity and species differences.
    Hermans JJ; Thijssen HH
    Biochem Pharmacol; 1989 Oct; 38(19):3365-70. PubMed ID: 2818630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of protein engineering to members of the old yellow enzyme family.
    Amato ED; Stewart JD
    Biotechnol Adv; 2015; 33(5):624-31. PubMed ID: 25940546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.
    Ordentlich A; Barak D; Sod-Moriah G; Kaplan D; Mizrahi D; Segall Y; Kronman C; Karton Y; Lazar A; Marcus D; Velan B; Shafferman A
    Chem Biol Interact; 2005 Dec; 157-158():191-8. PubMed ID: 16289014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.